<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36091707</PMID><DateRevised><Year>2022</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>The prevalence of sensory changes in post-COVID syndrome: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>980253</StartPage><MedlinePgn>980253</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">980253</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2022.980253</ELocationID><Abstract><AbstractText Label="UNLABELLED">Post-COVID syndrome can be defined as symptoms of COVID-19 that persist for longer than 12 weeks, with several studies reporting persistent symptoms relating to the sensory organs (eyes, ears, and nose). The aim of this systematic review was to examine the prevalence of persistent anosmia, hyposmia, ageusia, and hypogeusia, as well as eye/vision and ear/hearing related long-COVID symptoms. Authors searched the electronic databases from inception to November 2021. Search terms included words related to long-COVID, smell, taste, eyes/vision, and ears/hearing, with all observational study designs being included. A random effects meta-analysis was undertaken, calculating the prevalence proportions of anosmia, hyposmia, ageusia, and hypogeusia, respectively. From the initial pool, 21 studies met the inclusion criteria (total <i>n</i> 4,707; median <i>n</i> per study 125; median age = 49.8; median percentage female = 59.2%) and 14 were included in the meta-analysis The prevalence of anosmia was 12.2% (95% CI 7.7-16.6%), hyposmia 29.9% (95% CI 19.9-40%), ageusia 11.7% (95% CI 6.1-17.3%), and hypogeusia 31.2% (95% 16.4-46.1%). Several eye/vision and ear/hearing symptoms were also reported. Considering that changes in the sensory organs are associated with decreases in quality of life, future research should examine the etiology behind the persistent symptoms.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION" NlmCategory="UNASSIGNED">[www.crd.york.ac.uk/prospero], identifier [CRD42021292804].</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Trott, Driscoll and Pardhan.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trott</LastName><ForeName>Mike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Vision and Eye Research Institute, Anglia Ruskin University, Cambridge, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Driscoll</LastName><ForeName>Robin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Vision and Eye Research Institute, Anglia Ruskin University, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pardhan</LastName><ForeName>Shahina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Vision and Eye Research Institute, Anglia Ruskin University, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">smell</Keyword><Keyword MajorTopicYN="N">smell loss</Keyword><Keyword MajorTopicYN="N">taste</Keyword><Keyword MajorTopicYN="N">taste loss</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>12</Day><Hour>4</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36091707</ArticleId><ArticleId IdType="pmc">PMC9452774</ArticleId><ArticleId IdType="doi">10.3389/fmed.2022.980253</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization, WHO CORONAVIRUS. (COVID-19) Dashboard. Geneva: world health organization; (2022).</Citation></Reference><Reference><Citation>Alimohamadi Y, Sepandi M, Taghdir M, Hosamirudsari H. Determine the most common clinical symptoms in COVID-19 patients: a systematic review and meta-analysis. J Prevent Med Hygiene. (2020) 61:E304. 10.15167/2421-4248/jpmh2020.61.3.1530</Citation><ArticleIdList><ArticleId IdType="doi">10.15167/2421-4248/jpmh2020.61.3.1530</ArticleId><ArticleId IdType="pmc">PMC7595075</ArticleId><ArticleId IdType="pubmed">33150219</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakiba M, Nazemipour M, Heidarzadeh A, Mansournia M. Prevalence of asymptomatic COVID-19 infection using a seroepidemiological survey. Epidemiol Infect. (2020) 148:e300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7783089</ArticleId><ArticleId IdType="pubmed">33183367</ArticleId></ArticleIdList></Reference><Reference><Citation>Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann Internal Med. (2020) 173:362&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7281624</ArticleId><ArticleId IdType="pubmed">32491919</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Service. (2022). Available online at: https://www.nhs.uk/conditions/coronavirus-covid-19/symptoms/main-symptoms/ (Accessed May 10, 2022).</Citation></Reference><Reference><Citation>Hariyanto TI, Rizki NA, Kurniawan A. Anosmia/hyposmia is a good predictor of coronavirus disease 2019 (COVID-19) infection: a meta-analysis. Int Arch Otorhinolaryngol. (2021) 25:170&#x2013;4. 10.1055/s-0040-1719120</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1719120</ArticleId><ArticleId IdType="pmc">PMC7857970</ArticleId><ArticleId IdType="pubmed">33552295</ArticleId></ArticleIdList></Reference><Reference><Citation>Aziz M, Perisetti A, Lee-Smith WM, Gajendran M, Bansal P, Goyal H. Taste changes (dysgeusia) in COVID-19: a systematic review and meta-analysis. Gastroenterology. (2020) 159:1132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7199692</ArticleId><ArticleId IdType="pubmed">32387496</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasiri N, Sharifi H, Bazrafshan A, Noori A, Karamouzian M, Sharifi A. Ocular manifestations of COVID-19: a systematic review and meta-analysis. J Ophthalmic Vis Res. (2021) 16:103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841281</ArticleId><ArticleId IdType="pubmed">33520133</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Cheung SSL, Chan H, Zhang Y, Wang YM, Yip BH, et al. Myopia incidence and lifestyle changes among school children during the COVID-19 pandemic: A population-based prospective study. Br J Ophthalmol. (2021). 10.1136/bjophthalmol-2021-319307 [Epub ahead of print].</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2021-319307</ArticleId><ArticleId IdType="pubmed">34340973</ArticleId></ArticleIdList></Reference><Reference><Citation>Foreman J, Salim AT, Praveen A, Fonseka D, Ting DSW, He MG, et al. Association between digital smart device use and myopia: a systematic review and meta-analysis. Lancet Digital Health. (2021) 3:e806&#x2013;18. 10.1016/S2589-7500(21)00135-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(21)00135-7</ArticleId><ArticleId IdType="pubmed">34625399</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardhan S, Parkin J, Trott M, Driscoll R. Risks of digital screen time and recommendations for mitigating adverse outcomes in children and adolescents. J Sch Health. (2022) 92:765&#x2013;73. 10.1111/josh.13170</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/josh.13170</ArticleId><ArticleId IdType="pubmed">35253225</ArticleId></ArticleIdList></Reference><Reference><Citation>Trott M, Driscoll R, Irlado E, Pardhan S. Changes and correlates of screen time in adults and children during the COVID-19 pandemic: A systematic review and meta-analysis. EClinicalMedicine. (2022) 48:101452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9122783</ArticleId><ArticleId IdType="pubmed">35615691</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafari Z, Kolb BE, Mohajerani MH. Hearing loss, tinnitus, and dizziness in COVID-19: a systematic review and meta-analysis. Canad J Neurol Sci. (2021) 49:184&#x2013;95. 10.1017/cjn.2021.63</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2021.63</ArticleId><ArticleId IdType="pmc">PMC8267343</ArticleId><ArticleId IdType="pubmed">33843530</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence. NICE, SIGN and RCGP set out further details about the UK guideline on management of the long-term effects of COVID-19. London: National Institute for Health and Care Excellence; (2020).</Citation></Reference><Reference><Citation>National Health Service. (2022). Available online at: https://www.england.nhs.uk/coronavirus/post-covid-syndrome-long-covid/ (Accessed March 2, 2022).</Citation></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. (2021) 6:e005427. 10.1136/bmjgh-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, &#xf3;mez-Mayordomo VG, Florencio LL, Cuadrado ML, Plaza-Manzano G, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Internal Med. (2021) 92:55&#x2013;70. 10.1016/j.ejim.2021.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A, Cristillo V, Cotti Piccinelli S, Zoppi N, Bonzi G, Sattin D, et al. Long-term neurological manifestations of COVID-19: prevalence and predictive factors. Neurol Sci. (2021) 42:4903&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8439956</ArticleId><ArticleId IdType="pubmed">34523082</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V, Beer R, Schiefecker AJ, Kofler M, Lindner A, Mahlknecht P, et al. Neurological outcome and quality of life 3 months after COVID-19: A prospective observational cohort study. Eur J Neurol. (2021) 28:3348&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250725</ArticleId><ArticleId IdType="pubmed">33682276</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr&#xf9; G, Bertelloni D, Diolaiuti F, Mucci F, Di Giuseppe M, Biella M, et al. Long-COVID Syndrome? A Study on the persistence of neurological, psychological and physiological symptoms. Healthcare (Basel). (2021) 9:575. 10.3390/healthcare9050575</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare9050575</ArticleId><ArticleId IdType="pmc">PMC8152255</ArticleId><ArticleId IdType="pubmed">34068009</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. (2021) 38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. (2021) 11:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>I Corp. SPSS for Macintosh Version 26. New York, NY: IBM Corp; (2019).</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. (2002) 21:1539&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Smith GD. Meta-analysis bias in location and selection of studies. BMJ (1998) 316:61&#x2013;6. 10.1136/bmj.316.7124.61</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.316.7124.61</ArticleId><ArticleId IdType="pmc">PMC2665334</ArticleId><ArticleId IdType="pubmed">9451274</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (2008) 336:924&#x2013;6. 10.1136/bmj.39489.470347.AD</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Modesti PA, Reboldi G, Cappuccio FP, Agyemang C, Remuzzi G, Rapi S, et al. Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis. PLoS One. (2016) 11:e0147601&#x2013;0147601. 10.1371/journal.pone.0147601</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0147601</ArticleId><ArticleId IdType="pmc">PMC4725677</ArticleId><ArticleId IdType="pubmed">26808317</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells GA, Shea B, O&#x2019;Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses. Oxford: (2000).</Citation></Reference><Reference><Citation>Peterson J, Welch V, Losos M, Tugwell PJOOHRI. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. (Vol. 2). Ottawa, ON: Ottawa Hospital Research Institute; (2011). p. 1&#x2013;12.</Citation></Reference><Reference><Citation>Cristillo V, Pilotto A, Cotti Piccinelli S, Zoppi N, Bonzi G, Gipponi S, et al. Next study, age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection. J Am Geriatr Soc. (2021) 69:2778&#x2013;80. 10.1111/jgs.17296</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.17296</ArticleId><ArticleId IdType="pmc">PMC8242714</ArticleId><ArticleId IdType="pubmed">34019707</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of Long COVID prevalence and its relationship to epstein-barr virus reactivation. Pathogens. (2021) 10:763. 10.3390/pathogens10060763</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10060763</ArticleId><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein H, Asseo K, Karni N, Benjamini Y, Nir-Paz R, Muszkat M, et al. Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients. Clin Microbiol Infect. (2021) 27:769&#x2013;74. 10.1016/j.cmi.2021.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.02.008</ArticleId><ArticleId IdType="pmc">PMC7884919</ArticleId><ArticleId IdType="pubmed">33607252</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar J, Makheja K, Rahul F, Kumar S, Kumar M, Chand M, et al. Long-Term neurological impact of COVID-19. Cureus. (2021) 13:e18131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8528473</ArticleId><ArticleId IdType="pubmed">34692340</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov IM, Spiridonova E, Bobkova P, Gamirova A, Shikhaleva A, Andreeva M, et al. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study. Eur Respir J. (2022) 59:2101341. 10.1183/13993003.01341-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed AK, Sayad R, Mahmoud IA, El-Monem AMA, Badry SH, Ibrahim IH. &#x201c;Anosmia&#x201d; the mysterious collateral damage of COVID-19. J Neurovirol. (2022) 28:189&#x2013;200. 10.1007/s13365-022-01060-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-022-01060-9</ArticleId><ArticleId IdType="pmc">PMC8898086</ArticleId><ArticleId IdType="pubmed">35249186</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira LA, Lechien JR, Dore S, Boccaletti R, Saussez S, De Riu G. Specific Therapy of Olfactory Disorders in COVID-19 Patients is Essential for the Prevention of Long-term Dysfunction. Indian J Otolaryngol Head Neck Surg. (2021) 22:1&#x2013;2. 10.1007/s12070-021-02818-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12070-021-02818-z</ArticleId><ArticleId IdType="pmc">PMC8380412</ArticleId><ArticleId IdType="pubmed">34458129</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira LA, Hopkins C, Sandison A, Manca A, Machouchas N, Turilli D, et al. Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia. J Laryngol Otol. (2020) 134:1123&#x2013;7. 10.1017/S0022215120002455</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022215120002455</ArticleId><ArticleId IdType="pmc">PMC7729153</ArticleId><ArticleId IdType="pubmed">33190655</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty RL. Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health. Trends Mol Med. (2022):</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9212891</ArticleId><ArticleId IdType="pubmed">35810128</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendaus MA. Anosmia (smell failure) and dysgeusia (taste distortion) in COVID-19: it is genetic. J Biomol Struct Dyn. (2022) 93:31&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">35147485</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu DT, Prem B, Sharma G, Kaiser J, Besser G, Mueller CA. Depression symptoms and olfactory-related quality of life. Laryngoscope. (2022). 10.1002/lary.30122 [Epub ahead of print].</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.30122</ArticleId><ArticleId IdType="pmc">PMC9544892</ArticleId><ArticleId IdType="pubmed">35353380</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqahtani AS, Sultan AE, Alhazmi HO, Alenazi TMAAA. Impact Of covid related anosmia on patients quality of life at hail region. Eur J Mol Clin Med. (2022) 8:721&#x2013;9.</Citation></Reference><Reference><Citation>Malik P, Patel K, Pinto C, Jaiswal R, Tirupathi R, Pillai S, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)&#x2014;A systematic review and meta-analysis. J Med Virol. (2022) 94:253&#x2013;62. 10.1002/jmv.27309</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira LA, Gessa C, Deiana G, Salzano G, Maglitto F, Lechien JR, et al. The effects of persistent olfactory and gustatory dysfunctions on quality of life in long-COVID-19 patients. Life. (2022) 12:141. 10.3390/life12020141</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12020141</ArticleId><ArticleId IdType="pmc">PMC8878431</ArticleId><ArticleId IdType="pubmed">35207429</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xfc;emes-Villahoz NG, Burgos-Blasco B, Garc&#xed;a-Feijo&#xf3; J, S&#xe1;enz-Franc&#xe9;s F, Arriola-Villalobos P, Herrera de la Muela JM. Conjunctivitis in COVID-19 patients: frequency and clinical presentation. Graefe&#x2019;s Arch Clin Exp Ophthalmol. (2020) 258:2501&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7455778</ArticleId><ArticleId IdType="pubmed">32860573</ArticleId></ArticleIdList></Reference><Reference><Citation>Loffredo L, Pacella F, Pacella E, Tiscione G, Oliva A, Violi F. Conjunctivitis and COVID-19: a meta-analysis. J Med Virol. (2020) 92:1413&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7264785</ArticleId><ArticleId IdType="pubmed">32330304</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchinson CV, Maltby J, Badham SP, Jason LA. Vision-related symptoms as a clinical feature of chronic fatigue syndrome/myalgic encephalomyelitis? Evidence from the DePaul Symptom Questionnaire. Br J Ophthalmol. (2014) 98:144&#x2013;5. 10.1136/bjophthalmol-2013-304439</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2013-304439</ArticleId><ArticleId IdType="pubmed">24187048</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheppard AL, Wolffsohn JS. Digital eye strain: prevalence, measurement and amelioration. BMJ Open ophthalmol. (2018) 3:e000146. 10.1136/bmjophth-2018-000146</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjophth-2018-000146</ArticleId><ArticleId IdType="pmc">PMC6020759</ArticleId><ArticleId IdType="pubmed">29963645</ArticleId></ArticleIdList></Reference><Reference><Citation>Shigihara Y, Tanaka M, Watanabe Y. Relationship between fatigue and photosensitivity. Behav Med. (2010) 36:109&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">21186433</ArticleId></ArticleIdList></Reference><Reference><Citation>Viola P, Ralli M, Pisani D, Malanga D, Sculco D, Messina L, et al. Tinnitus and equilibrium disorders in COVID-19 patients: preliminary results. Eur Arch Oto-Rhino-Laryngol. (2021) 278:3725&#x2013;30. 10.1007/s00405-020-06440-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-06440-7</ArticleId><ArticleId IdType="pmc">PMC7582442</ArticleId><ArticleId IdType="pubmed">33095432</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D, Bridgewood C, Ramanan AV, Meaney JF, Watad A. COVID-19 vasculitis and novel vasculitis mimics. Lancet Rheumatol. (2021) 3:e224&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832717</ArticleId><ArticleId IdType="pubmed">33521655</ArticleId></ArticleIdList></Reference><Reference><Citation>Munro KJ, Uus K, Almufarrij I, Chaudhuri N, Yioe V. Persistent self-reported changes in hearing and tinnitus in post-hospitalisation COVID-19 cases. Int J Audiol. (2020) 59:889&#x2013;90. 10.1080/14992027.2020.1798519</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14992027.2020.1798519</ArticleId><ArticleId IdType="pubmed">32735466</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertlich M, Stihl C, L&#xfc;sebrink E, Hellmuth JC, Scherer C, Freytag S, et al. The course of subjective and objective chemosensory dysfunction in hospitalized patients with COVID-19: a 6-month follow-up. Eur Arch Otorhinolaryngol. (2021) 278:4855&#x2013;61. 10.1007/s00405-021-06796-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-021-06796-4</ArticleId><ArticleId IdType="pmc">PMC8035606</ArticleId><ArticleId IdType="pubmed">33837835</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis JP. The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses. Milb Q. (2016) 94:485&#x2013;514. 10.1111/1468-0009.12210</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1468-0009.12210</ArticleId><ArticleId IdType="pmc">PMC5020151</ArticleId><ArticleId IdType="pubmed">27620683</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Soddu D, Balbo PE, Baricich A, Zeppegno P, Avanzi GC, et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open. (2021) 4:e2036142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. (2020) 81:e4&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins C, Surda P, Safarian M, Vaira LA, Lechien JR, Saussez S, et al. Six month follow-up of self-reported loss of smell during the COVID-19 pandemic. Rhinology. (2021) 59:26&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">33320115</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Kim SW, Chang HH, Kwon KT, Bae S, Hwang S. Significance and associated factors of long-term sequelae in patients after acute COVID-19 Infection in Korea. Infect Chemother. (2021) 53:463&#x2013;76. 10.3947/ic.2021.0022</Citation><ArticleIdList><ArticleId IdType="doi">10.3947/ic.2021.0022</ArticleId><ArticleId IdType="pmc">PMC8511373</ArticleId><ArticleId IdType="pubmed">34405592</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Chiesa-Estomba CM, Beckers E, Mustin V, Ducarme M, Journe F, et al. Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients. J Intern Med. (2021) 290:451&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">33403772</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemh&#xf6;fer C, Sturm C, Loudovici-Krug D, Best N, Gutenbrunner C. The impact of Post-COVID-Syndrome on functioning&#x2013;results from a community survey in patients after mild and moderate SARS-CoV-2-infections in Germany. J Occupat Med Toxicol. (2021) 16:1&#x2013;9. 10.1186/s12995-021-00337-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12995-021-00337-9</ArticleId><ArticleId IdType="pmc">PMC8495185</ArticleId><ArticleId IdType="pubmed">34620202</ArticleId></ArticleIdList></Reference><Reference><Citation>Leth S, Gunst JD, Mathiasen V, Hansen K, S&#xf8;gaard O, &#xd8;stergaard L, et al. Persistent symptoms in patients recovering from COVID-19 in Denmark. Open Forum Infect Dis. (2021) 8:ofab042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7928683</ArticleId><ArticleId IdType="pubmed">33875970</ArticleId></ArticleIdList></Reference><Reference><Citation>Riestra-Ayora J, Yanes-Diaz J, Esteban-Sanchez J, Vaduva C, Molina-Quiros C, Larran-Jimenez A, et al. Long-term follow-up of olfactory and gustatory dysfunction in COVID-19: 6 months case&#x2013;control study of health workers. Eur Arch Oto-Rhino-Laryngol. (2021) 278:4831&#x2013;7. 10.1007/s00405-021-06764-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-021-06764-y</ArticleId><ArticleId IdType="pmc">PMC8004560</ArticleId><ArticleId IdType="pubmed">33774737</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M, Moreno E, Cari&#xf1;ena A, Rey T, Pita-Romero R, Leal S, et al. Quality of life, functional status, and persistent symptoms after intensive care of COVID-19 patients. Br J Anaesth. (2021) 126:e110&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833644</ArticleId><ArticleId IdType="pubmed">33413976</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Cao M, Zheng P, Shen W. Residual olfactory dysfunction in coronavirus disease 2019 patients after long term recovery. J Clin Neurosci. (2021) 93:31&#x2013;5. 10.1016/j.jocn.2021.07.050</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2021.07.050</ArticleId><ArticleId IdType="pmc">PMC8315939</ArticleId><ArticleId IdType="pubmed">34656257</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>